Global Gastrointestinal Drugs Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Market Analysis and Insights: Global Gastrointestinal Drugs Market
The global Gastrointestinal Drugs market size is projected to reach US$ 36120 million by 2026, from US$ 34430 million in 2020, at a CAGR of 0.8% during 2021-2026.
Global Gastrointestinal Drugs Scope and Segment
The global Gastrointestinal Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

Segment by Type, the Gastrointestinal Drugs market is segmented into
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug

Segment by Application, the Gastrointestinal Drugs market is segmented into
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

Gastrointestinal Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastrointestinal Drugs business, the date to enter into the Gastrointestinal Drugs market, Gastrointestinal Drugs product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Gastrointestinal Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Gastrointestinal Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Frequently Asked Questions